Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.
Orphan Drugs Now “Where the Money Is,” Says Willie Sutton’s Ghost
Why do pharma companies bother developing drugs for for a disorder affecting fewer than 200,000 people? Willie Sutton's ghost may have the answer.
New Big Pharma Economies of Scale
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?
New Big Pharma Economies of Scale
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?
Boehringer vs Facebook Social Media Socialism
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
Boehringer vs Facebook Social Media Socialism
Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.
Pharma Marketing News Vol. 10, No. 14: 22 September 2011
Welcome to Volume 10, Issue #14 (22 SEPTEMBER 2011) of Pharma Marketing News.
BI Masters the Art of WOM through Its “Parrots,” er, Spokespersons
Even Social Media Savvy, Personable, Fun-Loving Boehringer Ingelheim (BI) Can Bring Shame to the Pharmaceutical Industry!
No sooner did I give Boehringer Ingelheim (BI) kudos...
BI’s Famously Buxom and Unpronounceable YouTube Video
"In this brave new world there are better marketing tools than Facebook o Twitter," says Ray Cokes (@raycokes), the actor who plays the "new...
Kevin Nalty Once Again Working Inside Pharma
I have chronicled the career of Kevin Nalty (aka "Nalts") for a number of years (see , for example, "Nalts Talks About His Days...
